Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00707876 · ClinicalTrials.gov registry record · Phase 2
Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)
A Phase 2 study, sponsored by AMAG Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 119
- Enrollment target
NCT00707876 is a Phase 2 study that has completed, run by AMAG Pharmaceuticals. The registered enrollment target is 119 participants.
The verdict
NCT00707876, a Phase 2 study, has completed, sponsored by AMAG Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 119 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the difference between two magnetic resonance imaging (MRI) techniques for visualizing arteries. The study hypothesizes that one method that relies upon imaging flowing blood in the pelvic and leg arteries will not be as accurate or efficient as injecting a safe imaging agent to change the appearance of the blood on the MRI. Both methods will be compared with Digital Subtraction Angiography (DSA).
Interventions
- DRUG ferumoxytol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2008-09-01 |
| Est. Completion | 2020-08-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00707876
The ClinicalTrials.gov registry entry for NCT00707876 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AMAG Pharmaceuticals, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ferumoxytol is the first listed.
NCT00707876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00707876 about?
NCT00707876 is a clinical study titled "Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)". The purpose of this study is to compare the difference between two magnetic resonance imaging (MRI) techniques for visualizing arteries. The study hypothesizes that one method that relies upon imaging flowing blood in the pelvic and leg arteries will not be as accurate or efficient as injecting a sa...
What is the current status of trial NCT00707876?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 119 participants. The study started on 2008-09-01. Estimated completion is 2020-08-15.
What interventions are being tested in trial NCT00707876?
The interventions under investigation include: ferumoxytol (DRUG).
Who is sponsoring clinical trial NCT00707876?
This trial is sponsored by AMAG Pharmaceuticals, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.